Table 2.

In vitro EGFR-2, and Her-2 inhibitory effects of the synthesized compounds 5a, 5b and 5 g.

Comp. No.	IC50 (µM)a
	EGFR Inhibition	Her2 Inhibition
5a	0.116 ± 0.005	0.055 ± 0.003
5b	0.132 ± 0.006	0.21 ± 0.01
5 g	0.077 ± 0.004	0.085 ± 0.004
Erlotinib	0.09 ± 1.65	0.038 ± 0.002
Gefitinib	0.052 ± 0.78	0.072 ± 0.98

^aIC₅₀ value is the compound concentration required to produce 50% inhibition.